Takeda Pharmaceutical Company Limited Tax Expense Income At Applicable Tax Rate
Takeda Pharmaceutical Company Limited (TKPHF) reported Tax Expense Income At Applicable Tax Rate of JPY 53.54 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:TaxExpenseIncomeAtApplicableTaxRate · last filed 2025-06-25
| Period end | Tax Expense Income At Applicable Tax Rate 12 month |
|---|---|
| 2025-03-31 | 53.54B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 16.14B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 114.70B JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | 92.53B JPY 20-F · filed 2024-06-26 |
| 2021-03-31 | 112.00B JPY 20-F · filed 2023-06-28 |
| 2020-03-31 | -18.58B JPY 20-F · filed 2022-06-29 |
| 2019-03-31 | 39.02B JPY 20-F · filed 2021-06-29 |